Lataa...
Fetal Acrania (Exencephaly) in the Context of a Pregnant Female Taking Adalimumab for Psoriasis: A Case Report
Adalimumab is a fully human, recombinant, IgG1 monoclonal antibody that targets tumor necrosis factor-alpha (TNF-alpha). It has been established that adalimumab can cross the placenta and can be detected in the fetal circulation for up to 6 months postpartum. However, clinical studies have failed to...
Tallennettuna:
| Julkaisussa: | Biologics |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7666989/ https://ncbi.nlm.nih.gov/pubmed/33204064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S273762 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|